Administration of Testosterone Undecanoate in Postmenopausal Women: Effects on Androgens, Estradiol, and Gonadotrophins

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Menopause

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00042192-200007040-00007PMID 10914618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Androgen replacement in women: a commentary.

  1999cited by this paper
• Psychoendocrinological Assessment of the Menstrual Cycle: The Relationship Between Hormones, Sexuality, and Mood

  1997cited by this paper
• Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males.

  1996cited by this paper
• Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population.

  1996cited by this paper
• Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.

  1995cited by this paper
• A ten-year safety study of the oral androgen testosterone undecanoate.

  1994cited by this paper
• Comparison of plasma androgen glucuronide levels after percutaneous or peroral androgen treatment in men: evidence for important splanchnic contribution to plasma 17 beta-hydroxyandrogen glucuronides.

  1993cited by this paper
• A Comparison of Esterified Estrogens With and Without Methyltestosterone: Effects on Endometrial Histology and Serum Lipoproteins in Postmenopausal Women

  1993cited by this paper
• Regulation of estrogen biosynthesis by human adipose cells.

  1989cited by this paper
• Transdermal testosterone therapy in the treatment of male hypogonadism.

  1988cited by this paper
• Affective changes with estrogen and androgen replacement therapy in surgically menopausal women.

  1988cited by this paper
• Androgen abuse by athletes.

  1988cited by this paper
• Increasing circulating androgens with oral testosterone undecanoate in eugonadal men.

  1987cited by this paper
• Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroids.

  1987cited by this paper
• Biological actions of androgens.

  1987cited by this paper
• Serum bioavailability of sex steroid hormones.

  1986cited by this paper
• Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause.

  1985cited by this paper
• Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause.

  1985cited by this paper
• Serum Levels of 4‐Androstene‐3,17‐Dione in Menstruating and Postmenopausal Women

  1983cited by this paper
• Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.

  1982cited by this paper
• Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma.

  1981cited by this paper
• Plasma androgens after a single oral dose of testosterone undecanoate.

  1980cited by this paper
• EFFECTS OF ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MALE PATIENTS *

  1978cited by this paper
• Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man

  1976cited by this paper
• Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate.

  1975cited by this paper
• The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen.

  1975cited by this paper

• Managing Early Onset Osteoporosis: The Impact of Premature Ovarian Insufficiency on Bone Health

  2023cites this paper
• Androgens in premenopausal women and women with premature ovarian insufficiency

  2021cites this paper
• Testosterone in women--the clinical significance.

  2015cites this paper
• Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women

  2015cites this paper
• Fatigue and cognition - hormonal perspectives

  2012cites this paper
• Effects of testosterone and estrogen replacement on memory function

  2010cites this paper
• Effects of hormone treatment on sexual functioning in postmenopausal women

  2008cites this paper
• Safety of testosterone treatment in postmenopausal women.

  2007cites this paper
• Effects of testosterone treatment on endometrial proliferation in postmenopausal women.

  2007cites this paper
• Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women.

  2006cites this paper
• Female sexual satisfaction and pharmaceutical intervention: a critical review of the drug intervention studies in female sexual dysfunction.

  2006cites this paper
• i ntervention: a critical r eview of the drug i ntervention s tudies in Female s exual dysfunction

  2006cites this paper
• Androgens in peri- and postmenopausal women

  2006cites this paper
• Sexual Concerns–Menopause and Sexual Function

  2006cites this paper
• Formulations and use of androgens in women.

  2004cites this paper
• Androgen excess is the key element in polycystic ovary syndrome.

  2003cites this paper
• Pharmacokinetic Study in Women of Three Different Doses of a New Formulation of Oral Testosterone Undecanoate, Andriol Testocaps

  2003cites this paper
• Androgens and women at the menopause and beyond.

  2003cites this paper
• Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being

  2002cites this paper
• Menopause and Sexual Function

  2001cites this paper
• Ménopause et fonction sexuelle

  2001cites this paper
• Nams Continuing Medical Education Activity

  year unknowncites this paper